HIV

Infants with HIV could be spared from requiring lifetime antiretroviral (ART) if treated within hours of birth to disrupt formation of HIV viral reservoirs.

Negotiations to extend US global HIV/AIDS relief work are deadlocked; the Biden administration delayed its rule on the proposed menthol cigarette ban until March 2024 after lobbying by civil rights groups; federal agencies have partnered with a digital health company to create an at-home test-to-treat program for flu and COVID-19.

The researchers suggested prioritizing and optimizing HIV and general health services for children younger than age 5 living with HIV and receiving ART to help address their disproportionately poorer outcomes.

Research on HIV and aging should be the focus of future research as World AIDS Day brings the chronic illness to the forefront.

The Targeted Minimum Loss-based Estimation proved the most accurate capture-recapture model in estimating hidden populations of patients with HIV.

Patients who have HIV and are using antiretroviral therapy (ART) did not have adverse outcomes when using nivolumab for cancer treatment.

IQ score could be detrimentally influenced by an individual’s HIV infection, both through neurons and the gut.

Compared with infants born at term, infants born preterm following exposure to HIV had no observed increase in acquisition of HIV.

Residents grew more knowledgeable and more comfortable with using pre-exposure prophylaxis (PrEP) drugs for prevention against HIV after training was included in their residency program.

Medicare may cover full cost of preexposure prophylaxis drugs; rules aim to prevent excessive compensation in Medicare Advantage (MA) market; health officials advocate for widespread syphilis testing and intervention.

Mothers in the United States were surveyed about the time of disclosure of their HIV status to their children, with internalized stigma of HIV a significantly associated factor.

Men who had sex with men had increased HIV testing after participating in an intervention.

Patients with HIV who started highly active antiretroviral therapy (ART) for 6 months had an improved immunohematological profile by the end of the study.

Patients living with HIV had an interest in future use of telehealth due to high satisfaction in the care provided.

Individuals aged up to 24 years living with HIV were likely to be satisfied with and would recommend telehealth services to their friends, a recent study found.

People who inject drugs tended to have quicker COVID-19 vaccination uptake if they had HIV infection and viral suppression.

Patient comorbidities should be considered when prescribing antiretroviral therapy (ART) to treat HIV to avoid comedication drug toxicities.

Americans with college degrees live longer than those without; pre-exposure prophylaxis (PrEP) accessibility is low for Black women; new COVID-19 vaccine access is proving difficult for some Americans, as the COVID-19 vaccine card is being phased out.

Prevalence of hepatitis B virus (HBV) decreased in people living with HIV in Germany when vaccination coverage increased due to general recommendations and catch-up vaccination efforts.

Among Latino men who have sex with men (MSM), access to and use of pre-exposure prophylaxis (PrEP) remain at suboptimal levels, despite this population of individuals having disproportionately high rates of diagnosed HIV in the United States.

ViiV Healthcare is developing a self-injectable HIV drug similar to Cabenuva; HHS met with insurance companies to resolve COVID-19 vaccine coverage issues; the FDA has greenlit drugmaker Novo Nordisk to add reports of ileus, or intestinal blockage, to its Ozempic label.

Patients with limited English proficiency need their mobile health (mHealth) interventions tailored more closely to their needs to improve equity of access for patients with HIV.

Transmasculine individuals found mobile apps such as Transpire to be beneficial in increasing their access to information on sexual health.

The World Health Organization 2022 Africa regional report underestimated the incidence rate of tuberculosis in sub-Saharan African individuals living with HIV, according to a recent analysis.

Applying novel and effective approaches based on behavioral economics for pre-exposure prophylaxis (PrEP) dissemination programs could help to tailor the programs to the populations and settings of areas with high HIV burden.

An intervention for Black women living with HIV was shown to have improved perceived outcomes when incorporating a support network and when the program structure emphasized trust.

Women living with HIV reported their experiences living with the disease, highlighting discrimination in their social lives.

Patients with HIV were able to maintain care and achieve viral suppression with differentiated service delivery models with comparable effectiveness to the standard of care.

Access to HIV testing and pre-exposure prophylaxis could benefit from being tailored to the type of exchange sex.

Interventions should be tailored to local factors when aiming to reduce the risk of HIV in rural residents who use drugs.